Biopharmaceutics classification system: importance and inclusion in biowaiver guidance
Pharmacological therapy is essential in many diseases treatment and it is important that the medicine policy is intended to offering safe and effective treatment with affordable price to the population. One way to achieve this is through biowaiver, defined as the replacement of in vivo bioequivalenc...
Saved in:
Main Authors: | Lorena Barbosa Arrunátegui (Author), Neila Márcia Silva-Barcellos (Author), Karime Rezende Bellavinha (Author), Lisiane da Silveira Ev (Author), Jacqueline de Souza (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2015-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of experimental conditions on solubility measurements for BCS classification in order to improve the biowaiver guidelines
by: Patrícia Fernanda Monteiro, et al.
Published: (2021) -
ICH Guideline for Biopharmaceutics Classification System-Based Biowaiver (M9): Toward Harmonization in Latin American Countries
by: Claudia Miranda, et al.
Published: (2021) -
A Physiologically Based Pharmacokinetic Model for Studying the Biowaiver Risk of Biopharmaceutics Classification System Class I Drugs With Rapid Elimination: Dexketoprofen Trometamol Case Study
by: Xian Zhang, et al.
Published: (2022) -
Biopharmaceutics classification system (BCS)-based biowaiver for immediate release solid oral dosage forms of moxifloxacin hydrochloride (Moxiflox GPO) manufactured by the Government Pharmaceutical Organization (GPO)
by: Nawaphon Saelim, et al.
Published: (2016) -
Pediatric Biopharmaceutical Classification Systems (pBCS)
by: Justyna Srebro, et al.
Published: (2023)